Role of autologous platelet rich plasma (PRP) in limited alopecia areata in local population
DOI:
https://doi.org/10.66344/jpad.26.2.2016.50Keywords:
Platelet rich plasma (PRP), alopecia areataAbstract
Objective: To evaluate the efficacy and safety of autologous platelet rich plasma (PRP) in treatment of limited alopecia areata in local population.Methods: We performed a prospective study of 20 patients with Alopecia Areata. Both females and males with one or multiple patches of alopecia were included. Autologous PRP was injected once a month for three months. Primary endpoint was regrowth of hair. Digital photographs were taken before treatment and after each visit. Patients were further followed up for 6 months after treatment for any relapse or side effect. Results were assessed clinically and using digital photographs.Results: Out of 20 patients, 6 (30%) had excellent response, 5 (25%) with good response, 4 (20%) with fair and 5 (25%) poor response. Mild pain at the site of injection was noted for 5 to 30 min at injection site. No other side effect was noted nor reported by any of the patients. Patient compliance and satisfaction was good and all patients completed the treatment.Conclusion: Â PRP is safe, low-cost and effective treatment of alopecia areata.References
Orentreich N, Sturm HM, Weidman AI, Pelzig A. Local injection of steroids and hair regrowth in alopecias. Arch Dermatol. 1960;82:894-902.
Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol. 2003;49:96-8.
Rinaldi F, Sorbellini E, Coscera T. The role of platelet rich plasma to control anagen phase: Evaluation in vitro and in vivo in hair transplant and hair treatment. Int J Trichol.2011;3:S14-5.
Uebel CO, da Silva JB, Cantarelli D, Martins P. The role of platelet plasma growth factors in male pattern baldness surgery.Plast Reconstr Surg. 2006;118:1458-66.
Cianforlini M, Mattioli-Belmonte M, Manzotti S, Chiurazzi E, Piani M, Orlando Fet al. Effect of platelet rich plasma concentration on skeletal muscle regeneration: an experimental study. J BiolRegulHomeost Agents. 2015;29(4 Suppl):47-55.
Betsi EE, Germain E, Kalbermatten DF, Tremp M, Emmenegger V. Platelet-rich plasma injection is effective and safe for the treatment of alopecia. Eur J Plast Surg. 2013;36:407-12
Cervelli V, Garcovich S, Bielli A, Cervelli G, Curcio BC, Scioli MG et al. The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. BioMed Res Int.2014;2014:1-9
Tobin DJ, Gunin A, Magerl M, Handijski B, Paus R. Plasticity and cytokinetic dynamics of the hair follicle mesenchyme: implications for hair growth control. J Invest Dermatol. 2003;120:895-904.
Takikawa M, Nakamura S, Nakamura S, Ishirara M, Kishimoto S, Sasaki K et al. Enhanced effect of platelet-rich plasma containing a new carrier on hair growth. Dermatol Surg. 2011;37:1721-9.
Li ZJ, Choi HI, Choi DK, Sohn KC, Im M, Seo YJ. Autologous platelet-rich plasma: A potential therapeutic tool for promoting hair growth. Dermatol Surg. 2012;38:1040-6.
Kang J-S, Zheng Z, Choi MJ, Lee SH, Kim DY, Cho SB. The effect of CD34+cellcontaining autologous platelet-rich plasma injection on pattern hair loss: A preliminary study. J Eur Acad Dermatol Venereol. 2014;28:72-9.
Betsi EE, Germain E, Kalbermatten DF, Tremp M, Emmenegger V. Platelet-rich plasma injection is effective and safe for the treatment of alopecia. Eur J Plast Surg. 2013;36:407-12
Trink A.A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata. Br J Dermatol.2013;169:690-4.
Singh S. Role of platelet-rich plasma in chronic alopecia areata: Our centre experience Indian J Plast Surg. 2015;48:57- 9.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.